What is EndIt Laboratories?
EndIt Laboratories, Inc. operates as a specialized manufacturer in the consumer health space, primarily recognized for its EndIt! Topical Ointment. The company addresses a critical niche in dermatological care, providing therapeutic relief for conditions ranging from diaper rash and eczema to poison ivy. With a legacy spanning 52 years, the organization has cultivated a reputation for product efficacy and consumer trust, reinforced by a robust money-back guarantee and BBB accreditation. Its strategic positioning within the retail landscape, including a strong presence on major e-commerce platforms like Amazon, allows the company to maintain a competitive edge in the over-the-counter skin treatment market.
How much funding has EndIt Laboratories raised?
EndIt Laboratories has raised a total of $13K across 1 funding round:
Debt
$13K
Debt (2021): $13K with participation from PPP
Key Investors in EndIt Laboratories
PPP
Public-Private Partnership
What's next for EndIt Laboratories?
With the recent injection of capital, EndIt Laboratories is well-positioned to transition into a more aggressive growth phase. The strategic roadmap likely involves optimizing supply chain logistics to meet increasing retail demand and potentially diversifying its product portfolio to address broader skin health concerns. By maintaining its focus on high-quality, effective formulations, the company is poised to capture additional market share in the competitive topical ointment segment. Future initiatives will likely prioritize digital marketing expansion and strengthening distribution partnerships to ensure that its established brand remains a staple for consumers seeking reliable, fast-acting dermatological relief.
See full EndIt Laboratories company page
